1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. 2010, Lyon, France: International Agency for Research on Cancer, Available from: http://globocan.iarc.fr [accessed 23/02/2014]
2. Hsing AW, Devesa SS, Jin F, Gao YT: Rising incidence of prostate cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 1998, 7 (1): 83-84.
3. Ying-Xiu Z, Shu-Rong W: Secular trends in body mass index and the prevalence of overweight and obesity among children and adolescents in Shandong, China, from 1985 to 2010. J Public Health (Oxf). 2012, 34 (1): 131-137. 10.1093/pubmed/fdr053.
4. ᅟ: American Urological Association releases guidelines for the management of localized prostate cancer. Am Fam Physician. 1996, 53 (8): 2751-2752.
5. Ladjevardi S, Sandblom G, Berglund A, Varenhorst E: Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer. Eur Urol. 2010, 57 (4): 631-638. 10.1016/j.eururo.2009.03.007.